Investegate |Ultimovacs ASA Announcements | Ultimovacs ASA: Ultimovacs Presents TET Platform Pre-Clinical Data at AACR 2022 Supporting Clinical Development

Investegate announcements from Ultimovacs ASA, Ultimovacs Presents TET Platform Pre-Clinical Data at AACR 2022 Supporting Clinical Development

Related Keywords

Norway ,Louisiana ,United States ,Oslo ,New Orleans ,New Orleans Convention Center ,American ,Mary Ann Chang ,Orleans Convention Center ,American Association For Cancer Research ,Oslo University Hospital ,Clinical Development ,Ultimovacs Presents ,Pre Clinical Data ,Tetanus Epitope Targeting ,American Association ,Cancer Research ,Carlos De Sousa ,Chief Executive Officer ,Monday April ,Exhibit Hallsd H ,Poster Section ,Ultimovac Tetanus Epitope Targeting ,Ann Chang ,Investegate Announcements ,Investegate Company Announcements ,Ultimovacs Asa ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,